Cargando…

Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study

PURPOSE: Previous research has not provided us with a comprehensive picture of the longitudinal course of psychotic disorders in Black people living in Europe. We sought to investigate clinical outcomes and pattern of care in Black African and Black Caribbean groups compared with White British patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajnakina, Olesya, Lally, John, Di Forti, Marta, Kolliakou, Anna, Gardner-Sood, Poonam, Lopez-Morinigo, Javier, Dazzan, Paola, Pariante, Carmine M., Mondelli, Valeria, MacCabe, James, David, Anthony S., Gaughran, Fiona, Murray, Robin M., Vassos, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581822/ https://www.ncbi.nlm.nih.gov/pubmed/28681264 http://dx.doi.org/10.1007/s00127-017-1417-6

Ejemplares similares

T130. ASSOCIATIONS BETWEEN DIFFERENT TYPES OF CHILDHOOD ADVERSITY AND 5-YEAR OUTCOMES IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ajnakina, Olesya, et al.
Publicado: (2018)

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis
por: Ajnakina, Olesya, et al.
Publicado: (2014)

F68. PREMORBID IQ, EDUCATIONAL LEVEL AND JUMPING TO CONCLUSIONS AS PREDICTORS OF CLINICAL OUTCOME AT FIRST ONSET OF PSYCHOSIS OVER THE NEXT 4 YEARS: THE GAP STUDY
por: Rodriguez, Victoria, et al.
Publicado: (2018)

Structural Covariance of Cortical Gyrification at Illness Onset in Treatment Resistance: A Longitudinal Study of First-Episode Psychoses
por: Ajnakina, Olesya, et al.
Publicado: (2021)

O8.7. COGNITIVE SUBTYPES IN FIRST-EPISODE PSYCHOSIS AND ASSOCIATION TO TREATMENT RESPONSE
por: Russo, Manuela, et al.
Publicado: (2018)

The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
por: Kose, Melisa, et al.
Publicado: (2021)

Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study
por: Gaughran, Fiona, et al.
Publicado: (2019)

Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019)

35.4 A PUBLIC HEALTH APPROACH TO THE PREVENTION OF PSYCHOSIS
por: Murray, Robin, et al.
Publicado: (2018)

Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme
por: Ajnakina, Olesya, et al.
Publicado: (2017)

A Systematic Review of Cognitive Function in First-Episode Psychosis, Including a Discussion on Childhood Trauma, Stress, and Inflammation
por: Aas, Monica, et al.
Publicado: (2014)

Social Disadvantage: Cause or Consequence of Impending Psychosis?
por: Stilo, Simona A., et al.
Publicado: (2013)

T14. ASSESSING DIFFERENCES IN INFLAMMATORY MARKERS BETWEEN FIRST EPISODE PSYCHOSIS PATIENTS AND HEALTHY CONTROLS: THE IMPORTANCE OF CONTROLLING FOR CONFOUNDING FACTORS
por: Giordano, Annalisa, et al.
Publicado: (2018)

Serum and gene expression profile of cytokines in first-episode psychosis
por: Di Nicola, Marco, et al.
Publicado: (2013)

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis
por: Beck, Katherine, et al.
Publicado: (2015)

O4.5. INVESTIGATING GENETIC PROFILES ASSOCIATED WITH ‘REAL WORLD’ CLINICAL OUTCOMES IN PSYCHOSIS: A RETROSPECTIVE COHORT STUDY
por: Francis, Emma, et al.
Publicado: (2018)

Impact of Different Childhood Adversities on 1-Year Outcomes of Psychotic Disorder in the Genetics and Psychosis Study
por: Trotta, Antonella, et al.
Publicado: (2016)

O5.2. PREDICTORS OF CARDIOMETABOLIC RISK IN THE YEAR AFTER ONSET OF PSYCHOSIS: A PROSPECTIVE COHORT STUDY
por: Gaughran, Fiona, et al.
Publicado: (2018)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
por: Mondelli, Valeria, et al.
Publicado: (2015)

T183. LOW LEVELS OF VITAMIN D ARE ASSOCIATED WITH REDUCED CORTICAL THICKNESS AND SURFACE AREA IN FRONTAL, TEMPORAL AND OCCIPITAL REGIONS IN FIRST-EPISODE PSYCHOSIS PATIENTS
por: Ciufolini, Simone, et al.
Publicado: (2020)

S186. THE EFFECTS OF CHILDHOOD TRAUMA ON HIPPOCAMPAL VOLUME IN FIRST EPISODE PSYCHOSIS: DOES CORTISOL PLAY A ROLE?
por: Ciufolini, Simone, et al.
Publicado: (2020)

Globally Efficient Brain Organization and Treatment Response in Psychosis: A Connectomic Study of Gyrification
por: Palaniyappan, Lena, et al.
Publicado: (2016)

Further evidence of a cumulative effect of social disadvantage on risk of psychosis
por: Stilo, S. A., et al.
Publicado: (2017)

Clinical correlates of vitamin D deficiency in established psychosis
por: Lally, J., et al.
Publicado: (2016)

White matter integrity as a predictor of response to treatment in first episode psychosis
por: Reis Marques, Tiago, et al.
Publicado: (2014)

S123. TREATMENT RESISTANT SCHIZOPHRENIA AND GYRIFICATION-BASED CONNECTOME
por: Ajnakina, Olesya, et al.
Publicado: (2018)

A comparison between self-report and interviewer-rated retrospective reports of childhood abuse among individuals with first-episode psychosis and population-based controls
por: Gayer-Anderson, Charlotte, et al.
Publicado: (2020)

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?
por: Iyegbe, Conrad, et al.
Publicado: (2018)

Prevention of psychosis: moving on from the at-risk mental state to universal primary prevention
por: Murray, Robin M., et al.
Publicado: (2021)

The relationship between nicotine and psychosis
por: Quigley, Harriet, et al.
Publicado: (2019)

Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

30.1 IMMUNE PATHOGENESIS OF PSYCHOSIS: THE CHALLENGE OF CO-MORBIDITY
por: Upthegrove, Rachel, et al.
Publicado: (2018)

Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion
por: Heslin, Margaret, et al.
Publicado: (2017)

Familial risk and childhood adversity interplay in the onset of psychosis
por: Trotta, Antonella, et al.
Publicado: (2015)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

It is time to start taking tobacco seriously as a risk factor for psychosis: self‐medication cannot explain the association
por: MacCabe, J. H.
Publicado: (2018)

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis
por: Shirazi, Ayala, et al.
Publicado: (2016)

What can neuroimmunology teach us about the symptoms of long-COVID?
por: Mondelli, Valeria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jn73bcl3f3p4c4ei5bo15l29e7